More than half of patients affected by cancer experience pain of moderate-to-severe
intensity, often in multiple sites, and of different etiologies and underlying mechanisms. The …

Background and aims This living and systematic review aimed to provide an updated
summary of the available evidence on pain undertreatment prevalence in patients with …

BACKGROUND: The safety and efficacy of intrathecal drug delivery systems (IDDSs) for the
treatment of cancer-related pain have been demonstrated in randomized controlled clinical …

Thanks to the progress in early diagnosis and treatment of cancer, the life expectancy of
cancer patients has now increased. Patients are, therefore, more likely to experience their …

OBJECTIVES To examine the rates and predictors of long‐term opioid therapy in older
cancer survivors. DESIGN Retrospective cohort study. SETTING Texas, United States …

Purpose Prescription opioid medication can be of great benefit for cancer patients and
survivors who suffer from cancer-related pain throughout their cancer care trajectory …

PURPOSE Opioids are the primary choice for managing chronic cancer pain. However,
many nonopioid therapies are currently prescribed for chronic cancer pain with little …

Introduction: Undertreatment of cancer pain is associated with inadequate assessment and
inconsistent or non-standardized classification, resulting in failure to both appreciate its …

Background. Cancer‐related pain (CRP) is a major problem with a potential negative impact
on quality of life of the patients and their caregivers. Purpose. To assess the adequacy of …

Context In patients with cancer pain, identifying a neuropathic pain component (NPC) may
inform the selection of subsequent therapeutic interventions. Objectives The objective of this …